Resistance	Microbe	Outcome
Dihydrostreptomycin /	Escherichia coli	See: Table 4 AMR+ (n) AMR- (n) Total (n) Aminoglycoside use 13 20 No use 99 230
Kanamycin /	Escherichia coli	See: Table 4 AMR+ (n) AMR- (n) Total (n) Aminoglycoside use 6 20 No use 30 230